NCT05890092RecruitingNot Applicable
Vulvar Disease in Nigeria - Registry ( Observationsl Study)
KDRS ltd1 site in 1 country1,000 target enrollmentStarted: May 3, 2023Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 1,000
- Locations
- 1
- Primary Endpoint
- Prevalence of Vulvar disease
Study Overview
Brief Summary
Vulvar disease in Nigeria A look at awareness within patients and health practitioners, self-reported and actual prevalence within communities in Nigeria
Study Design
- Study Type
- Observational
- Observational Model
- Other
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 10 Years to 90 Years (Child, Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •biological females - afab
Exclusion Criteria
- •none-afab
Outcomes
Primary Outcomes
Prevalence of Vulvar disease
Time Frame: 1-12 months
Awareness of Vulvar disease (descriptor)
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Active, not recruiting
Not Applicable
DeVEnIR: Defining Vulvovaginal Candidiasis - Elements of Infection and RemedyVulvovaginal CandidiasisNCT06397248University Hospital, Antwerp300
Completed
Not Applicable
An Internet-based Information Platform for Vulvodynia PatientsVulvodyniaNCT02809612Uppsala University52
Unknown
Phase 1
Use of Oral Probiotics as an Adjunctive Therapy to Fluconazole in the Treatment of Yeast VaginitisVaginal CandidiasisNCT00479947Faith Mediplex100
Completed
Not Applicable
EMBRACE Vaginal Morbidity Studycancer of the cervix10013364cervical cancerNL-OMON39692Medical University of Vienna, Austria Department of Radiotherapy35
Terminated
Not Applicable
Vulvar Mucosal Specialty Clinic Chart ReviewVulvar DiseaseVulvodyniaLichen PlanusLichen SclerosusNCT02881229Northwestern University719